Literature DB >> 11514721

Differential permissivity to measles virus infection of human and CD46-transgenic murine lymphocytes.

Alexey Evlashev1, Hélène Valentin1, Pierre Rivailler1, Olga Azocar1, Chantal Rabourdin-Combe1, Branka Horvat1.   

Abstract

Analysis of measles virus (MV) pathogenesis requires the development of an adequate small animal model of MV infection. In this study, permissivity to MV infection was compared in human and transgenic murine T lymphocytes, expressing different levels of the human MV receptor, CD46. Whereas MV binding and entry correlated with CD46 expression, higher levels of MV replication were always observed in human T lymphocytes. This suggests the existence of intracellular factors, acting posterior to virus entry, that could limit MV replication in murine lymphocytes and should be considered when creating new animal models of MV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514721     DOI: 10.1099/0022-1317-82-9-2125

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

Review 1.  T-cell stimulation and regulation: with complements from CD46.

Authors:  Claudia Kemper; James W Verbsky; Jeffrey D Price; John P Atkinson
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

2.  Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s).

Authors:  Séverine Vincent; Isabelle Tigaud; Henriette Schneider; Christian J Buchholz; Yusuke Yanagi; Denis Gerlier
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 3.  Making it to the synapse: measles virus spread in and among neurons.

Authors:  V A Young; G F Rall
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

4.  Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide.

Authors:  R M Myers; S M Greiner; M E Harvey; G Griesmann; M J Kuffel; S A Buhrow; J M Reid; M Federspiel; M M Ames; D Dingli; K Schweikart; A Welch; A Dispenzieri; K-W Peng; S J Russell
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

Review 5.  Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin.

Authors:  Lauren A O'Donnell; Glenn F Rall
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-24       Impact factor: 7.285

6.  Interplay between virus-specific effector response and Foxp3 regulatory T cells in measles virus immunopathogenesis.

Authors:  Caroline I Sellin; Jean-François Jégou; Joëlle Renneson; Johan Druelle; T Fabian Wild; Julien C Marie; Branka Horvat
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.